Abstract
This short review addresses the most important and common metabolic disorders that result in abnormal neuroimaging studies in clinical practice. In these cases, the patient’s medical history is of the utmost importance, as imaging findings may be relatively nonspecific. This chapter concentrates on disorders that produce somewhat specific brain findings and thus are amenable to diagnosis by the radiologist. Most of these disorders affect the gray matter. Diffuse and focal involvement of the gray matter is generally secondary to ischemia (focal cortical involvement may be seen with seizures) and is not addressed here. Instead, the focus here is on abnormalities involving the subcortical gray matter.
Chapter PDF
Similar content being viewed by others
Keywords
- Hepatic Encephalopathy
- Globus Pallidus
- Thrombotic Thrombocytopenic Purpura
- Wilson Disease
- Central Pontine Myelinolysis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Etsuo I, Shinichi H, Narumi Y et al (1991) Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 179:551–555
Krieger D, Krieger S, Jansen O et al (1995) Manganese and chronic hepatic encephalopathy. Lancet 346:270–274
Pomier-Layrargues G, Spahr L, Butterworth RF (1995) Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345:735
Fell JM, Reynolds AP, Meadows N et al (1996) Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 347:1218–1221
Mirowitz SA, Westrich TJ (1992) Basal ganglial signal intensity alterations: reversal after discontinuation of parenteral manganese administration. Radiology 185:535–536
Okamoto K, Ito J, Furusawa T et al (1998) Reversible hyperintensity of the anterior pituitary gland on T1-weighted MR images in a patient receiving temporary parenteral nutrition. AJNR Am J Neuroradiol 19:1287–1289
Ross BD, Jacobson S, Villamil F et al (1994) Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 193:457–463
Van Den Heuvel AG, Van der Grond J, Van Rooij LG et al (1997) Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy. Radiology 203:539–543
Lee J, Lacomis D, Comu S et al (1998) Acquired hepatocerebral degeneration: MR and pathologic findings. AJNR Am J Neuroradiol 19:485–487
Albernaz VS, Castillo M, Mukherji SK et al (1997) Facies to remember, No. 11, Part I: The challenge. Int J Neuroradiol 3:206–217
Magalhaes AC, Caramelli P, Menezes JR et al (1994) Wilson’s disease: MRI with clinical correlation. Neuroradiology 36:97–100
King AD, Walshe JM, Kendall BE et al (1996) Cranial MR imaging in Wilson’s disease. AJR Am J Roentgenol 167:1579–1584
van Wassenaer-van Hall HN, van den Heuvel AG, Algra A et al (1996) Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 198:531–536
Engelbrecht V, Schlaug G, Hefter H et al (1995) MRI of the brain in Wilson disease: T2 signal loss under therapy. J Comput Assist Tomogr 19(4):635–638
Moore KR, Osborn AG, Townsend JJ et al (1997) The imaging and pathologic spectrum of hemolytic-uremic syndromethrombotic thrombocytopenic purpura (HUS-TTP Syndrome). Int J Neuroradiol 3:147–159
Okada J, Yoshikawa K, Matsuo H et al (1991) Reversible MRI and CT findings in uremic encephalopathy. Neuroradiology 33:524–526
Shimono T, Hatabu H, Kasagi K et al (1999) Rapid progression of pituitary hyperplasia in humans with primary hypothyroidism: demonstration with MR imaging. Radiology 213:383–388
Burke JW, Williamson BR, Hurst RW (1998) “Idiopathic” cerebellar calcifications: association with hypothyroidism. Radiology 167:533–536
Wesley EE, Moorehead B, Haponik EF (1995) Emergency evaluation and management of 30 patients with carbon monoxide poisoning. Am J Med 98:145–155
Roberts J (2000) Ethylene glycol intoxication and multiple trauma. Emerg Med 32:8
O’Brien KL, Selanikio JD, Hecdivert C et al (1998) Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. JAMA 279:1175–1180
Nau T, Seitz H, Kapral S et al (1999) Ethylene glycol poisoning and brain injury — a dangerous combination. Anasthesiologie 34:318–320
Tayfun C, Kurtaran HK, Bulakbasi N et al (1999) Cerebral and orbital magnetic resonance imaging findings in methyl alcohol intoxication. Int J Neuroradiol 5:145–150
Kuteifan K, Oesterle H, Tajahmady T et al (1998) Necrosis and haemorrhage of the putamen in methanol poisoning shown on MRI. Neuroradiology 40:158–160
Committee on Substance Abuse and Committee on Native American Child Health (1996) Inhalant abuse. Pediatrics 97:420–423
Unger E, Alexander A, Fritz, T et al (1994) Toluene abuse: physical basis for hypointensity of the basal ganglia on T2-weighted MR images. Radiology 193:473–476
Xiong L, Matthes JD, Li J, Jinkins JR (1993) MR imaging of “spray heads”: toluene abuse via aerosol paint inhalation. AJNR Am J Neuroradiol 14:1195–1199
Pema PJ, Horak HA, Wyatt RH (1998) Myelopathy caused by nitrous oxide toxicity. AJNR Am J Neuroradiol 19:894–896
Harper C, Bitterworth R (1997) Nutritional and metabolic disorders. In: Graham DI, Lantos PL (eds) Greenfield’s Neuropathology, 6th ed. Arnold, London, pp 613–615
Brody BA (1996) The Wernicke-Korsakoff syndrome. Int J Neuroradiol 2:216–230
Gallucci M, Bozzao A, Splendiani A et al (1990) Wernicke encephalopathy: MR findings in five patients. AJNR Am J Neuroradiol 11:887–892
Victor M (1990) MR in the diagnosis of Wernicke-Korsakoff syndrome. AJNR Am J Neuroradiol 11:895–896
Antunez E, Estruch R, Cardenal C et al (1998) Usefulness of CT and MR imaging in the diagnosis of acute Wernicke’s Encephalopathy. AJR Am J Roentgenol 171:1131–1137
Ishii K, Ikejiri Y, Sasaki M et al (1999) Regional cerebral glucose metabolism and blood flow in a patient with Marchiafava-Bignami disease. AJNR Am J Neuroradiol 20:1249–1251
Fraser CL, Arieff AI (1997) Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med 102:67–77
Laureno R, Karp BI (1997) Myelinolysis after correction of hyponatremia. Ann Intern Med 126:57–62
Berg D, Hoggenmuller U, Hofmann E et al (2000) The basal ganglia in haemochromatosis. Neuroradiology 42:9–13
Hermann W, Reuter M, Barthel H et al (2000) Diagnosis of Hallervorden-Spatz disease using MRI, I-123-beta-CITSPECT and I-123-IBZM-SPECT. Eur Neurol 43:187–188
Shan DE, Ho DM, Chang C et al (1998) Hemichorea-hemiballism: an explanation for MR signal changes. AJNR Am J Neuroradiol 19:863–870
Kashihara K, Nakashima S, Kohira I et al (1998) Hyperintense basal ganglia on T1-weighted MR images in a patient with central nervous system Lupus and Chorea. AJNR Am J Neuroradiol 19:284–286
Castillo M, Mukherji SK (1998) Pits, patches, and proturberances: No. 10, Part I. The challenge. Int J Neuroradiol 4:349–356
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Italia
About this chapter
Cite this chapter
Castillo, M. (2008). Imaging the Effects of Systemic Metabolic Diseases on the Brain. In: Hodler, J., Von Schulthess, G.K., Zollikofer, C.L. (eds) Diseases of the Brain, Head & Neck, Spine. Springer, Milano. https://doi.org/10.1007/978-88-470-0840-3_9
Download citation
DOI: https://doi.org/10.1007/978-88-470-0840-3_9
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0839-7
Online ISBN: 978-88-470-0840-3
eBook Packages: MedicineMedicine (R0)